You are here

Women's Imaging


A new study published in the January issue of the Journal of Ultrasound in Medicine has shown that a 3D power Doppler ultrasound can more accurately determine altered fetal growth restriction (FGR) in fetuses vulnerable to developing abnormal cerebral vascular flow patterns than a standard 2D Doppler ultrasound.  

Breast cancer mortality rates in the U.S. have decreased by roughly 50 percent from 2000 to 2012, according to a new stimulation modeling study released online Jan. 9 by JAMA.

A Children’s National Health System team has found velocity-selective arterial spin labeling (VSASL), an advanced MRI technology, can detect early signs of global placental perfusion in pregnancies complicated by fetal congenital heart disease (CHD).

The American Institute of Ultrasound in Medicine (AIUM) developed a task force to develop a standardized consensus-based curriculum and competency assessment tools for OB-GYN ultrasounds, with the aim they would be used in residency programs.

Researchers, investigating how community practices are following breast cancer screening guidelines, found that high-risk individuals, especially those with a family history of the disease, were not receiving additional MRI scans to help in early detection.


Recent Headlines

Government-run insurance marketplaces often fail to help women choose appropriate plans

Women seeking information about which plans cover which breast-health services in Affordable Care Act (ACA) marketplaces have been getting a lot of underinformed advice from customer-service reps. As a result, more than a few women have likely been buying plans that won’t meet their needs. 

Contralateral breast cancer a risk for women with dense tissue

Compared with breast-cancer patients who have nondense tissue, those with dense tissue are at significantly elevated risk of developing a tumor in the opposite breast. 

Breast imaging research team calls for raising the acceptable recall rate

Breast imaging practices that have screening recall rates of at least 12 percent but less than 14 percent are in the “sweet spot” for optimal detection of breast cancer. Practices that call back more than 14 percent of screening patients see little incremental benefit, while those that come in under 10 percent risk missing many cancers. 

Danish study challenges value of screening mammography, draws sharp criticism from U.S. orgs

European researchers have reviewed a huge mammography dataset and found no association between screening mammography and a reduction in the incidence of advanced breast cancer. 

35 is too young to start screening mammography: Irish study

In Ireland, national guidelines call for women to begin routine screening mammograms at 35 years old. That’s too soon, according to the authors of a new analysis showing just 2.1 cancers per 1,000 symptomatic women aged 35 to 39 who were screened over a five-year period. 

The future is bright for aspiring breast imagers—but where best to practice?

The medical job market is ripe for radiologists specialized in breast imaging, and new rads considering this career path would do well to read “What You Need to Know—A Primer for Radiologists Entering Breast Imaging,” published online Dec. 22 in the Journal of the American College of Radiology.

Expanded genetic testing points more women to screening breast MRI

Testing for gene mutations beyond just BRCA1 and BRCA2 would indicate screening breast MRI and other proactive measures for many women who would not have been considered candidates for such measures going by family history alone, according to a large-sample study published online Dec. 21 in the Journal of the American College of Radiology.

The defeat of breast cancer will mark the beginning of the end for cancer, period

If the war on cancer is ever decisively and finally won, chances are good the world will look back and see that the first major turning point was the eradication of breast cancer. And this initial victory will be remembered as a smart place to have started. 

Breast radiologists increasingly collaborating with—and adding value to—multidisciplinary care teams

Outcomes stand to be optimized when breast care is delivered in a multidisciplinary milieu—as long as such care incorporates screening, diagnosis of borderline and high-risk lesions, and management of the breast cancer patient.

For high-risk women, even small lesions on breast MRI call for prompt assessment and biopsy

A U.K. study based on a departmental audit has confirmed previous research suggesting that MRI-detected small enhancing masses and new small enhancing foci, including those smaller than 5 millimeters, should be considered suspicious in women at high risk for breast cancer.